Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
GOGL - Golden Ocean Group Limited - Stock Price Chart
TickerGOGL [NASD, RUT]
CompanyGolden Ocean Group Limited
CountryBermuda
IndustryMarine Shipping
Market Cap2.82BEPS (ttm)0.93
P/E15.15EPS this Y149.63%
Forward P/E8.73EPS next Y15.97%
PEG-EPS past 5Y-0.88%
P/S3.02EPS next 5Y-0.20%
P/B1.47EPS Q/Q844.32%
Dividend9.29%Sales Q/Q25.55%
Insider Own40.54%Inst Own30.92%
Insider Trans0.00%Inst Trans-5.03%
Short Float3.25%EarningsMay 22/b
Analyst Recom2.09Target Price15.82
Avg Volume1.76M52W Range6.89 - 15.77
May-22-24Downgrade Jefferies Buy → Hold $15.50
May-22-24 08:05AM GOGL Q1 2024 Presentation (GlobeNewswire) -10.27%
06:52AM GOGL Stock Earnings: Golden Ocean Group Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:02AM Golden Ocean Group: Q1 Earnings Snapshot (Associated Press Finance)
02:00AM GOGL First Quarter 2024 Results (GlobeNewswire)
May-17-24 09:42AM Golden Ocean (GOGL) to Report Q1 Earnings: What's in Store? (Zacks)
May-13-24 02:30AM GOGL Invitation to presentation of Q1 2024 Results (GlobeNewswire)
May-08-24 06:15PM Golden Ocean Group (GOGL) Stock Moves -0.94%: What You Should Know (Zacks)
May-01-24 06:15PM Golden Ocean Group (GOGL) Rises As Market Takes a Dip: Key Facts (Zacks)
Apr-29-24 05:23PM GOGL 2024 AGM Results Notification (GlobeNewswire)
Apr-25-24 06:15PM Golden Ocean Group (GOGL) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
USCA - Xtrackers MSCI USA Climate Action Equity ETF - Stock Price Chart
TickerUSCA [NYSE]
CompanyXtrackers MSCI USA Climate Action Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Factor & Thematic
IndexMSCI USA Climate Action Index
TagsU.S., equity, climate-change, mid-large-cap
Sector/Theme Region
Dividend0.91%Active/Passive
Total Holdings308AUM2.08B
Flows% 1M0.15%Flows% 3M-0.92%
Flows% YTD-1.07%Flows% 1Y
Return% 1Y30.91%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume45.08K52W Range24.97 - 33.26
IGTA - Inception Growth Acquisition Ltd - Stock Price Chart
TickerIGTA [NASD]
CompanyInception Growth Acquisition Ltd
CountryUSA
IndustryShell Companies
Market Cap62.30MEPS (ttm)0.15
P/E76.76EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.23EPS Q/Q-44.42%
Dividend-Sales Q/Q-
Insider Own23.32%Inst Own46.89%
Insider Trans0.00%Inst Trans26.16%
Short Float0.12%Earnings-
Analyst Recom-Target Price-
Avg Volume22.21K52W Range10.28 - 11.24
May-08-24 07:00AM Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period (GlobeNewswire)
May-07-24 04:00PM Inception Growth Acquisition Limited Announces Listing Transfer to the Nasdaq Capital Market (GlobeNewswire)
Apr-08-24 07:45AM Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period (GlobeNewswire)
Mar-01-24 07:00AM Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period (GlobeNewswire)
Feb-12-24 09:00AM Inception Growth Acquisition Limited (NASDAQ: IGTA) Announces Filing of Registration Statement on Form S-4 in Connection with Its Proposed Business Combination with AgileAlgo, a Leading AI Company (GlobeNewswire)
Feb-07-24 04:15PM Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period (GlobeNewswire)
Jan-09-24 07:00AM Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period (GlobeNewswire)
Dec-05-23 04:00PM Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period (GlobeNewswire)
Nov-07-23 04:05PM Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period (GlobeNewswire)
Oct-06-23 05:00PM Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period (GlobeNewswire)
QOWZ - Invesco Nasdaq Free Cash Flow Achievers ETF - Stock Price Chart
TickerQOWZ [NASD]
CompanyInvesco Nasdaq Free Cash Flow Achievers ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Dividend & Fundamental
IndexNasdaq US FCF Achievers Indx
TagsU.S., equity, cash-cow
Sector/Theme Region
Dividend0.11%Active/Passive
Total Holdings52AUM2.89M
Flows% 1M0.00%Flows% 3M0.00%
Flows% YTD0.00%Flows% 1Y
Return% 1Y-Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume3.51K52W Range23.79 - 29.23
Dec-06-23 09:00AM Invesco Adds Two First-to-Market ETFs to its Robust Suite of Smart Beta ETFs (PR Newswire)
HIO - Western Asset High Income Opportunity Fund Inc - Stock Price Chart
TickerHIO [NYSE]
CompanyWestern Asset High Income Opportunity Fund Inc
CountryUSA
IndustryClosed-End Fund - Debt
Market Cap357.57MEPS (ttm)0.30
P/E12.53EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S9.58EPS next 5Y-
P/B0.91EPS Q/Q-
Dividend10.74%Sales Q/Q3.60%
Insider Own-Inst Own40.43%
Insider Trans-Inst Trans-
Short Float0.04%Earnings-
Analyst Recom-Target Price-
Avg Volume377.77K52W Range3.52 - 4.03
May-22-24 08:00AM Franklin Templeton Fund Adviser, LLC Announces Distributions for the Months of June, July and August 2024 (Business Wire)
Apr-17-24 08:00AM Western Asset High Income Opportunity Fund Inc. Announces Results of Annual Meeting of Stockholders (Business Wire)
Mar-04-24 08:00AM Western Asset High Income Opportunity Fund Inc. (NYSE: HIO) Announces Portfolio Management Team Update (Business Wire)
Feb-20-24 08:00AM Western Asset High Income Opportunity Fund Inc. Announces Financial Position as of December 31, 2023 (Business Wire)
08:00AM Franklin Templeton Fund Adviser, LLC Announces Distributions for the Months of March, April and May 2024 (Business Wire)
Nov-14-23 08:00AM Legg Mason Partners Fund Advisor, LLC Announces Distributions for the Months of December 2023, January and February 2024 (Business Wire)
Aug-17-23 08:00AM Western Asset High Income Opportunity Fund Inc. Announces Financial Position as of June 30, 2023 (Business Wire)
Aug-02-23 08:00AM Legg Mason Partners Fund Advisor, LLC Announces Distributions for the Months of September, October and November 2023 (Business Wire)
May-15-23 08:00AM Legg Mason Partners Fund Advisor, LLC Announces Distributions for the Months of June, July and August 2023 (Business Wire)
Feb-15-23 08:00AM Western Asset High Income Opportunity Fund Inc. Announces Financial Position as of December 31, 2022 (Business Wire)
LSTA - Lisata Therapeutics Inc - Stock Price Chart
TickerLSTA [NASD]
CompanyLisata Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap25.80MEPS (ttm)-2.46
P/E-EPS this Y-19.38%
Forward P/E-EPS next Y12.82%
PEG-EPS past 5Y36.51%
P/S-EPS next 5Y-
P/B0.60EPS Q/Q15.93%
Dividend-Sales Q/Q-
Insider Own20.20%Inst Own8.89%
Insider Trans0.00%Inst Trans-20.77%
Short Float0.22%EarningsMay 09/a
Analyst Recom1.00Target Price14.50
Avg Volume13.23K52W Range1.95 - 4.53
May-20-24 03:58PM Sector Update: Health Care Stocks Softer Late Afternoon (MT Newswires)
11:14AM Lisata Therapeutics Receives European Medicines Agency Pediatric Waiver for Pancreatic Cancer Treatment (MT Newswires)
08:30AM Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer (GlobeNewswire)
May-13-24 10:45AM Lisata Therapeutics gets 2024 off to a strong start as it prepares for crucial ASCEND trial results (News Direct) -5.93%
May-10-24 12:39PM Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:10PM Q1 2024 Lisata Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-24 05:47PM Lisata Therapeutics Net Loss Declines From a Year Earlier (Exec Edge) +5.93%
04:05PM Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-08-24 08:00AM Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events (GlobeNewswire)
May-02-24 08:00AM Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024 (GlobeNewswire)
SKY - Skyline Champion Corp - Stock Price Chart
TickerSKY [NYSE, RUT]
CompanySkyline Champion Corp
CountryUSA
IndustryResidential Construction
Market Cap4.16BEPS (ttm)2.54
P/E28.37EPS this Y-1.54%
Forward P/E18.74EPS next Y23.79%
PEG17.73EPS past 5Y-
P/S2.05EPS next 5Y1.60%
P/B2.92EPS Q/Q-95.25%
Dividend-Sales Q/Q9.12%
Insider Own2.83%Inst Own102.26%
Insider Trans-1.24%Inst Trans-1.16%
Short Float2.90%EarningsMay 21/a
Analyst Recom2.57Target Price77.71
Avg Volume244.10K52W Range52.12 - 86.71
May-21-24 08:52PM SKY Stock Earnings: Skyline Champion Misses EPS, Misses Revenue for Q4 2024 (InvestorPlace)
05:20PM Skyline (SKY) Misses Q4 Earnings and Revenue Estimates (Zacks)
04:18PM Skyline: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:10PM Skyline Champion Announces Fourth Quarter and Full Year Fiscal 2024 Results; Announces New $100 Million Share Repurchase Program (Business Wire)
May-01-24 09:30AM Skyline Champion Corporation Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call (Business Wire)
Feb-07-24 08:34AM Skyline Champion Corporation (NYSE:SKY) Q3 2024 Earnings Call Transcript (Insider Monkey)
Feb-05-24 05:30PM Skyline (SKY) Q3 Earnings and Revenues Top Estimates (Zacks)
04:45PM Skyline Champion Corp (SKY) Faces Headwinds as Q3 Fiscal 2024 Earnings Dip (GuruFocus.com)
04:33PM Skyline: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:15PM Skyline Champion Announces Third Quarter Fiscal 2024 Results (Business Wire)
CAE - Cae Inc. - Stock Price Chart
TickerCAE [NYSE]
CompanyCae Inc.
CountryCanada
IndustryAerospace & Defense
Market Cap5.98BEPS (ttm)0.65
P/E29.02EPS this Y47.00%
Forward P/E16.87EPS next Y19.17%
PEG2.36EPS past 5Y-
P/S1.80EPS next 5Y12.31%
P/B1.70EPS Q/Q-28.06%
Dividend0.21%Sales Q/Q6.93%
Insider Own0.17%Inst Own72.24%
Insider Trans0.00%Inst Trans-0.35%
Short Float0.57%EarningsMay 28/b
Analyst Recom1.82Target Price22.91
Avg Volume570.63K52W Range18.26 - 25.04
May-22-24Downgrade Canaccord Genuity Buy → Hold
May-22-24 10:00AM CAE (CAE) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks) -5.19%
May-21-24 04:30PM CAE announces re-baselining of its Defense business, Defense impairments, accelerated risk recognition on Legacy Contracts and appointment of Nick Leontidis as COO (PR Newswire)
08:40AM CAE Downgraded to Hold at Desjardins (MT Newswires)
May-16-24 04:50PM CAE Appoints Boralex Chief Executive Patrick Decostre to its Board (MT Newswires)
04:30PM CAE announces changes to its Board of Directors (PR Newswire)
May-15-24 03:01PM Charles Brandes Amplifies Stake in CAE Inc, Marking a Strategic Portfolio Adjustment (GuruFocus.com)
May-04-24 07:38AM 23 Most Profitable Stocks of the Last 12 Months (Insider Monkey)
Apr-24-24 11:33AM Cadence Design Systems, Inc. (NASDAQ:CDNS) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:11AM US Aerospace and Defense Earnings a "Positive Read Through for CAE," RBC Says (MT Newswires)
Apr-16-24 07:15AM NAV CANADA and CAE form partnership to train Air Traffic Controllers and Flight Service Specialists (PR Newswire)
IMCR - Immunocore Holdings plc ADR - Stock Price Chart
TickerIMCR [NASD]
CompanyImmunocore Holdings plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap2.52BEPS (ttm)-1.21
P/E-EPS this Y-74.19%
Forward P/E-EPS next Y-32.74%
PEG-EPS past 5Y-
P/S9.48EPS next 5Y-
P/B7.06EPS Q/Q-16.29%
Dividend-Sales Q/Q30.20%
Insider Own3.04%Inst Own79.52%
Insider Trans-7.81%Inst Trans22.95%
Short Float9.42%EarningsMay 08/b
Analyst Recom1.28Target Price84.76
Avg Volume471.35K52W Range42.21 - 76.98
May-08-24 01:54PM IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:35AM Immunocore Holdings' Shares Fall After Q1 Net Loss Widens (MT Newswires)
08:38AM Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts (GuruFocus.com)
07:00AM Immunocore reports first quarter financial results and provides a business update (GlobeNewswire)
Apr-29-24 07:15AM Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target (MT Newswires)
Apr-24-24 10:00AM Immunocore announces upcoming presentation and posters at ASCO 2024 (GlobeNewswire)
Apr-04-24 04:00PM Immunocore to present at upcoming investor conferences (GlobeNewswire)
Mar-13-24 11:07AM Billionaires Biotech Bets: 3 Stocks Dominating Bill Gates Portfolio (InvestorPlace)
Mar-05-24 04:30PM Immunocore presented two posters at CROI 2024 (GlobeNewswire)
Mar-01-24 07:00AM Immunocore to present at upcoming investor conferences (GlobeNewswire)
ASND - Ascendis Pharma A/S ADR - Stock Price Chart
TickerASND [NASD]
CompanyAscendis Pharma A/S ADR
CountryDenmark
IndustryBiotechnology
Market Cap7.42BEPS (ttm)-9.64
P/E-EPS this Y41.06%
Forward P/E-EPS next Y90.49%
PEG-EPS past 5Y-19.87%
P/S20.85EPS next 5Y-
P/B-EPS Q/Q-17.85%
Dividend-Sales Q/Q188.79%
Insider Own1.33%Inst Own107.12%
Insider Trans0.00%Inst Trans3.65%
Short Float6.62%EarningsMay 02/a
Analyst Recom1.46Target Price177.02
Avg Volume355.46K52W Range83.75 - 161.00
May-15-24 01:57PM FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months (Benzinga)
10:44AM FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing (Zacks)
May-14-24 04:07PM US Equity Markets Close Higher Tuesday as Producer Prices Rise (MT Newswires) -5.45%
03:20PM Ascendis Pharma Says US FDA Extends Review Period on Hypoparathyroidism Treatment; Shares Drop (MT Newswires)
02:47PM UPDATE 2-US FDA extends review of Ascendis Pharma's hormone disorder therapy (Reuters)
02:38PM FDA extends review of Ascendis Pharma's hormone disorder therapy (Reuters)
02:31PM Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism (GlobeNewswire)
May-13-24 09:29AM Ascendis Says Late-Stage Trial Shows 'Significant' Improvements in Kidney Function for Adults Treated With TransCon PTH (MT Newswires)
08:30AM Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial (GlobeNewswire)
May-09-24 08:30AM Latest Clinical and Quality-of-Life Data for TransCon PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024 (GlobeNewswire)
1⋯10⋯121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.